4,170 research outputs found
Projection-based measurement and identification
A recently developed Projection-based Digital Image Correlation (P-DVC)
method is here extended to 4D (space and time) displacement field measurement
and mechanical identification based on a single radiograph per loading step
instead of volumes as in standard DVC methods. Two levels of data reductions
are exploited, namely, reduction of the data acquisition (and time) by a factor
of 1000 and reduction of the solution space by exploiting model reduction
techniques. The analysis of a complete tensile elastoplastic test composed of
127 loading steps performed in 6 minutes is presented. The 4D displacement
field as well as the elastoplastic constitutive law are identified. Keywords:
Image-based identification, Model reduction, Fast 4D identification, In-situ
tomography measurements. INTRODUCTION Identification and validation of
increasingly complex mechanical models is a major concern in experimental solid
mechanics. The recent developments of computed tomography coupled with in-situ
tests provide extremely rich and non-destructive analyses [1]. In the latter
cases, the sample was imaged inside a tomograph, either with interrupted
mechanical load or with a continuously evolving loading and on-the-fly
acquisitions (as ultra-fast X-ray synchrotron tomography, namely, 20 Hz full
scan acquisition for the study of crack propagation [2]). Visualization of fast
transformations, crack openings, or unsteady behavior become accessible.
Combined with full-field measurements, in-situ tests offer a quantitative basis
for identifying a broad range of mechanical behavior.Comment: SEM 2019, Jun 2019, Reno, United State
Data extraction methods for systematic review (semi)automation: A living systematic review [version 1; peer review: awaiting peer review]
Background: The reliable and usable (semi)automation of data
extraction can support the field of systematic review by reducing the
workload required to gather information about the conduct and
results of the included studies. This living systematic review examines
published approaches for data extraction from reports of clinical
studies.
Methods: We systematically and continually search MEDLINE,
Institute of Electrical and Electronics Engineers (IEEE), arXiv, and the
dblp computer science bibliography databases. Full text screening and
data extraction are conducted within an open-source living systematic
review application created for the purpose of this review. This
iteration of the living review includes publications up to a cut-off date
of 22 April 2020.
Results: In total, 53 publications are included in this version of our
review. Of these, 41 (77%) of the publications addressed extraction of
data from abstracts, while 14 (26%) used full texts. A total of 48 (90%)
publications developed and evaluated classifiers that used
randomised controlled trials as the main target texts. Over 30 entities
were extracted, with PICOs (population, intervention, comparator,
outcome) being the most frequently extracted. A description of their
datasets was provided by 49 publications (94%), but only seven (13%)
made the data publicly available. Code was made available by 10 (19%)
publications, and five (9%) implemented publicly available tools.
Conclusions: This living systematic review presents an overview of
(semi)automated data-extraction literature of interest to different
types of systematic review. We identified a broad evidence base of
publications describing data extraction for interventional reviews and
a small number of publications extracting epidemiological or diagnostic accuracy data. The lack of publicly available gold-standard
data for evaluation, and lack of application thereof, makes it difficult
to draw conclusions on which is the best-performing system for each
data extraction target. With this living review we aim to review the
literature continually
The translational challenges of precision oncology
The translational challenges in the field of precision oncology are in part related to the biological complexity and diversity of this disease. Technological advances in genomics have facilitated large sequencing efforts and discoveries that have further supported this notion. In this review, we reflect on the impact of these discoveries on our understanding of several concepts: cancer initiation, cancer prevention, early detection, adjuvant therapy and minimal residual disease monitoring, cancer drug resistance, and cancer evolution in metastasis. We discuss key areas of focus for improving cancer outcomes, from biological insights to clinical application, and suggest where the development of these technologies will lead us. Finally, we discuss practical challenges to the wider adoption of molecular profiling in the clinic and the need for robust translational infrastructure
Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer
UNLABELLED: The cGAS-STING pathway serves a critical role in anticancer therapy. Particularly, response to immunotherapy is likely driven by both active cGAS-STING signaling that attracts immune cells, and by the presence of cancer neoantigens that presents as targets for cytotoxic T cells. Chromosomal instability (CIN) is a hallmark of cancer, but also leads to an accumulation of cytosolic DNA that in turn results in increased cGAS-STING signaling. To avoid triggering the cGAS-STING pathway, it is commonly disrupted by cancer cells, either through mutations in the pathway or through transcriptional silencing. Given its effect on the immune system, determining the cGAS-STING activation status prior to treatment initiation is likely of clinical relevance. Here, we used combined expression data from 2,307 tumors from five cancer types from The Cancer Genome Atlas to define a novel cGAS-STING activity score based on eight genes with a known role in the pathway. Using unsupervised clustering, four distinct categories of cGAS-STING activation were identified. In multivariate models, the cGAS-STING active tumors show improved prognosis. Importantly, in an independent bladder cancer immunotherapy-treated cohort, patients with low cGAS-STING expression showed limited response to treatment, while patients with high expression showed improved response and prognosis, particularly among patients with high CIN and more neoantigens. In a multivariate model, a significant interaction was observed between CIN, neoantigens, and cGAS-STING activation. Together, this suggests a potential role of cGAS-STING activity as a predictive biomarker for the application of immunotherapy. SIGNIFICANCE: The cGAS-STING pathway is induced by CIN, triggers inflammation and is often deficient in cancer. We provide a tool to evaluate cGAS-STING activity and demonstrate clinical significance in immunotherapy response
Rhesus TRIM5Ξ± disrupts the HIV-1 capsid at the inter-hexamer interfaces
TRIM proteins play important roles in the innate immune defense against retroviral infection, including human immunodeficiency virus type-1 (HIV-1). Rhesus macaque TRIM5Ξ± (TRIM5Ξ±rh) targets the HIV-1 capsid and blocks infection at an early post-entry stage, prior to reverse transcription. Studies have shown that binding of TRIM5Ξ± to the assembled capsid is essential for restriction and requires the coiled-coil and B30.2/SPRY domains, but the molecular mechanism of restriction is not fully understood. In this study, we investigated, by cryoEM combined with mutagenesis and chemical cross-linking, the direct interactions between HIV-1 capsid protein (CA) assemblies and purified TRIM5Ξ±rh containing coiled-coil and SPRY domains (CC-SPRYrh). Concentration-dependent binding of CC-SPRYrh to CA assemblies was observed, while under equivalent conditions the human protein did not bind. Importantly, CC-SPRYrh, but not its human counterpart, disrupted CA tubes in a non-random fashion, releasing fragments of protofilaments consisting of CA hexamers without dissociation into monomers. Furthermore, such structural destruction was prevented by inter-hexamer crosslinking using P207C/T216C mutant CA with disulfide bonds at the CTD-CTD trimer interface of capsid assemblies, but not by intra-hexamer crosslinking via A14C/E45C at the NTD-NTD interface. The same disruption effect by TRIM5Ξ±rh on the inter-hexamer interfaces also occurred with purified intact HIV-1 cores. These results provide insights concerning how TRIM5Ξ± disrupts the virion core and demonstrate that structural damage of the viral capsid by TRIM5Ξ± is likely one of the important components of the mechanism of TRIM5Ξ±-mediated HIV-1 restriction. Β© 2011 Zhao et al
Early Clinical and Subclinical Visual Evoked Potential and Humphrey's Visual Field Defects in Cryptococcal Meningitis.
Cryptococcal induced visual loss is a devastating complication in survivors of cryptococcal meningitis (CM). Early detection is paramount in prevention and treatment. Subclinical optic nerve dysfunction in CM has not hitherto been investigated by electrophysiological means. We undertook a prospective study on 90 HIV sero-positive patients with culture confirmed CM. Seventy-four patients underwent visual evoked potential (VEP) testing and 47 patients underwent Humphrey's visual field (HVF) testing. Decreased best corrected visual acuity (BCVA) was detected in 46.5% of patients. VEP was abnormal in 51/74 (68.9%) right eyes and 50/74 (67.6%) left eyes. VEP P100 latency was the main abnormality with mean latency values of 118.9 (Β±16.5) ms and 119.8 (Β±15.7) ms for the right and left eyes respectively, mildly prolonged when compared to our laboratory references of 104 (Β±10) ms (p<0.001). Subclinical VEP abnormality was detected in 56.5% of normal eyes and constituted mostly latency abnormality. VEP amplitude was also significantly reduced in this cohort but minimally so in the visually unimpaired. HVF was abnormal in 36/47 (76.6%) right eyes and 32/45 (71.1%) left eyes. The predominant field defect was peripheral constriction with an enlarged blind spot suggesting the greater impact by raised intracranial pressure over that of optic neuritis. Whether this was due to papilloedema or a compartment syndrome is open to further investigation. Subclinical HVF abnormalities were minimal and therefore a poor screening test for early optic nerve dysfunction. However, early optic nerve dysfunction can be detected by testing of VEP P100 latency, which may precede the onset of visual loss in CM
Improving response rates using a monetary incentive for patient completion of questionnaires: an observational study
Background: Poor response rates to postal questionnaires can introduce bias and reduce the statistical power of a study. To improve response rates in our trial in primary care we tested the effect of introducing an unconditional direct payment of 5 pound for the completion of postal questionnaires. Methods: We recruited patients in general practice with knee problems from sites across the United Kingdom. An evidence-based strategy was used to follow-up patients at twelve months with postal questionnaires. This included an unconditional direct payment of 5 pound to patients for the completion and return of questionnaires. The first 105 patients did not receive the 5 pound incentive, but the subsequent 442 patients did. We used logistic regression to analyse the effect of introducing a monetary incentive to increase the response to postal questionnaires. Results: The response rate following reminders for the historical controls was 78.1% ( 82 of 105) compared with 88.0% ( 389 of 442) for those patients who received the 5 pound payment (diff = 9.9%, 95% CI 2.3% to 19.1%). Direct payments significantly increased the odds of response ( adjusted odds ratio = 2.2, 95% CI 1.2 to 4.0, P = 0.009) with only 12 of 442 patients declining the payment. The incentive did not save costs to the trial - the extra cost per additional respondent was almost 50 pound. Conclusion: The direct payment of 5 pound significantly increased the completion of postal questionnaires at negligible increase in cost for an adequately powered study
Structural and Biochemical Characterization of SrcA, a Multi-Cargo Type III Secretion Chaperone in Salmonella Required for Pathogenic Association with a Host
Many Gram-negative bacteria colonize and exploit host niches using a protein apparatus called a type III secretion system (T3SS) that translocates bacterial effector proteins into host cells where their functions are essential for pathogenesis. A suite of T3SS-associated chaperone proteins bind cargo in the bacterial cytosol, establishing protein interaction networks needed for effector translocation into host cells. In Salmonella enterica serovar Typhimurium, a T3SS encoded in a large genomic island (SPI-2) is required for intracellular infection, but the chaperone complement required for effector translocation by this system is not known. Using a reverse genetics approach, we identified a multi-cargo secretion chaperone that is functionally integrated with the SPI-2-encoded T3SS and required for systemic infection in mice. Crystallographic analysis of SrcA at a resolution of 2.5 Γ
revealed a dimer similar to the CesT chaperone from enteropathogenic E. coli but lacking a 17-amino acid extension at the carboxyl terminus. Further biochemical and quantitative proteomics data revealed three protein interactions with SrcA, including two effector cargos (SseL and PipB2) and the type III-associated ATPase, SsaN, that increases the efficiency of effector translocation. Using competitive infections in mice we show that SrcA increases bacterial fitness during host infection, highlighting the in vivo importance of effector chaperones for the SPI-2 T3SS
Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity
Most computational methods that infer somatic copy number alterations (SCNAs) from bulk sequencing of DNA analyse tumour samples individually. However, the sequencing of multiple tumour samples from a patientβs disease is an increasingly common practice. We introduce Refphase, an algorithm that leverages this multi-sampling approach to infer haplotype-specific copy numbers through multi-sample phasing. We demonstrate Refphaseβs ability to infer haplotype-specific SCNAs and characterise their intra-tumour heterogeneity, to uncover previously undetected allelic imbalance in low purity samples, and to identify parallel evolution in the context of whole genome doubling in a pan-cancer cohort of 336 samples from 99 tumours
- β¦